This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
D.M. Bottomley & G.W. Hanks (1990). Subcutaneous midazolam infusion in palliative care. Journal of Pain and Symptom Management, 5, 259–261.
W. Breitbart (2002). Spirituality and meaning in supportive care: Spirituality- and meaning-centered group psychotherapy interventions in advanced cancer. Supportive Care in Cancer 10, 272–280.
H.M. Chochinov , T. Hack , T. Hassard , (2005). Dignity therapy: A novel psychotherapeutic intervention for patients near the end of life. Journal of Clinical Oncology, 23, 5520–5525.
C. Classen , L.D. Butler , C. Koopman , (2001). Supportive-expressive group therapy and distress in patients with metastatic breast cancer: A randomized clinical intervention trial. Archives of General Psychiatry, 58, 494–501.
F.D. Ferris (2004). Last hours of living. Clinics in Geriatric Medicine, 20, 641–667.
P.J. Goodwin , M. Leszcz , M. Ennis , (2001). The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine, 345, 1719–1726.
C.S. Han & Y.K. Kim (2004). A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45, 297–301.
J. Homsi , D. Walsh , K.A. Nelson , (2000). Methylphenidate for depression in hospice practice: A case series. American Journal of Hospice & Palliative Care, 17, 393–398.
S.K. Inouye , Y. Zhang , L. Han , (2006). Recoverable cognitive dysfunction at hospital admission in older persons during acute illness. Journal of General Internal Medicine 21, 1276–1281.
G. Martinon-Torres , M. Fioravanti , & E.J. Grimley (2004). Trazodone for agitation in dementia. Cochrane Database of Systematic Reviews, CD004990.
M.A. Menza , K.R. Kaufman , & A. Castellanos (2000). Modafinil augmentation of antidepressant treatment in depression. Journal of Clinical Psychiatry, 61, 378–381.
T. Morita , Y. Tei , & S. Inoue (2003). Agitated terminal delirium and association with partial opioid substitution and hydration. Journal of Palliative Medicine, 6, 557–563.
P. Rousseau (2005). Palliative sedation in the control of refractory symptoms. Journal of Palliative Medicine, 8, 10–12.
M. Rozans , A. Dreisbach , J.J. Lertora , (2002). Palliative uses of methylphenidate in patients with cancer: A review. Journal of Clinical Oncology, 20, 335–339.
L.S. Schneider , P.N. Tariot , K.S. Dagerman , (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525–1538.
G.E. Simon , B.M. Psaty , J.B. Hrachovec , (2005). Principles for evidence-based drug formulary policy. Journal of General Internal Medicine, 20, 964–968.
A. Sipahimalani & P.S. Masand (1998). Olanzapine in the treatment of delirium. Psychosomatics, 39, 422–430.
A. Sood , D.L. Barton , & C.L. Loprinzi (2006). Use of methylphenidate in patients with cancer. American Journal of Hospice & Palliative Care, 23, 35–40.
D. Spiegel , J.R. Bloom , & I. Yalom (1981). Group support for patients with metastatic cancer. A randomized outcome study. Archives of General Psychiatry, 38, 527–533.
L.J. Standish , L. Kozak , & S. Congdon (2008). Acupuncture is underutilized in hospice and palliative medicine. American Journal of Hospice & Palliative Care, 25, 298–308.
F. Stiefel , R. Fainsinger , & E. Bruera (1992). Acute confusional states in patients with advanced cancer. Journal of Pain and Symptom Management, 7, 94–98.
M.E. Thase , E.S. Friedman , M.M. Biggs , (2007). Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: A STAR*D report. American Journal of Psychiatry, 164, 739–752.
M.H. Trivedi , A.J. Rush , S.R. Wisniewski , (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 163, 28–40.